Ovid Therapeutics Inc (OVID)
3.00
-0.05
(-1.64%)
USD |
NASDAQ |
May 10, 16:00
Ovid Therapeutics Total Assets (Quarterly): 144.03M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 144.03M |
September 30, 2023 | 125.03M |
June 30, 2023 | 136.23M |
March 31, 2023 | 143.37M |
December 31, 2022 | 155.27M |
September 30, 2022 | 165.03M |
June 30, 2022 | 177.33M |
March 31, 2022 | 191.10M |
December 31, 2021 | 194.54M |
September 30, 2021 | 207.09M |
June 30, 2021 | 218.00M |
March 31, 2021 | 237.46M |
December 31, 2020 | 75.93M |
September 30, 2020 | 91.60M |
June 30, 2020 | 45.36M |
Date | Value |
---|---|
March 31, 2020 | 61.72M |
December 31, 2019 | 80.84M |
September 30, 2019 | 40.69M |
June 30, 2019 | 54.91M |
March 31, 2019 | 66.66M |
December 31, 2018 | 47.65M |
September 30, 2018 | 60.39M |
June 30, 2018 | 68.61M |
March 31, 2018 | 78.67M |
December 31, 2017 | 89.46M |
September 30, 2017 | 97.57M |
June 30, 2017 | 108.01M |
March 31, 2017 | 47.20M |
December 31, 2016 | 53.03M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
40.69M
Minimum
Sep 2019
237.46M
Maximum
Mar 2021
133.97M
Average
143.37M
Median
Mar 2023
Total Assets (Quarterly) Benchmarks
Ligand Pharmaceuticals Inc | 913.87M |
NovaBay Pharmaceuticals Inc | 9.034M |
Palatin Technologies Inc | 13.55M |
iBio Inc | 34.02M |
Theriva Biologics Inc | 48.73M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 56.23M |
Shareholders Equity (Quarterly) | 87.80M |
Current Ratio | 9.552 |